Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Fulgent Genetics Inc

FLGT ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Healthcare Facilities & Services ·

USA Small Cap Analyst: HOLD

Last Close

$19.45

▼ -2.26%

Market Cap $535.17M · Vol 104.34K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$535.17M

Small Cap

Div Yield

N/A

EPS Growth

-640.48%

YoY

RSI (14)

63.98

Momentum

Beta

0.93

vs Market

52W High

$31.04

37.34% below

52W Low

$13.46

44.50% above

Volume

104.34K

Avg 103.88K

P/B

0.73

Price-to-book

ROE

1.18%

Return on equity

Free Float

62.19%

Public shares

Shariah Compliance8 STANDARDS

✗ Fulgent Genetics Inc (FLGT) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does FLGT pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+4.23%

-1.12%

+13.68%

-15.76%

YTD

-25.96%

-10.66%

-42.20%

-79.21%

Financials & Valuation

TTM · Annual

Total Revenue	$322.67M
Net Income	$-61,631,000.00
Revenue Growth (YoY)	+4.38%
Gross Margin	38.07%
Operating Margin	-28.23%
Net Profit Margin	-19.10%
ROE	1.18%
ROA · ROIC	-5.76% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	2.51
P/B	0.73
P/FCF	N/A
EPS Growth	-640.48%
Outstanding Shares	27.52M

Technical Indicators

50-Day SMA	$19.44
200-Day SMA	$21.03
RSI (14)	63.98
Beta	0.93
52-Week High	$31.04
52-Week Low	$13.46

Volume Today	104.34K
Avg Daily Volume (30D)	103.88K
Relative Volume	1.00x
Volatility (10D)	34.03
Volatility (30D)	68.62
Free Float	62.19%

Analyst Consensus

HOLD

Current Price $19.45

Mean Target $19.00

52W Low$13.46 52W High$31.04

Current

Target

$13.46 $31.04

Current Analyst target

-2.31% downside risk · 1 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00DW0QQM5

ISINUS3596641098

CountryUnited States of America

Sub-IndustryMedical & Diagnostic Laboratories

Earnings DateNov 5, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

NTRA Natera Inc -1.30% LH Labcorp Holdings Inc +0.89% RDNT RadNet Inc -2.77% LALPATHLAB.NS Dr. Lal PathLabs Ltd -0.55% WGS GeneDx Holdings Corp -2.15%

Company Profile

Fulgent Genetics, Inc. is a technology-based company with a laboratory services business and a therapeutic development business. Its laboratory services business includes technical laboratory and testing services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a novel nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. Its testing services include comprehensive anatomic pathology testing services, including gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology, and precision diagnostics testing services, including next-generation sequencing (NGS), tests for biopharma research and clinical tests for rare disease, hereditary cancer, reproductive health, and many other diseases.